Tom Teerlink - Search Results

Year	Number of Results
2002	3
2003	4
2004	10
2005	9
2006	12
2007	19
2008	23
2009	13
2010	10
2011	12
2012	11
2013	13
2014	5
2015	1
2016	1
2017	3
2018	1
2024	0

1

Letter by Teerlink regarding article, "L-arginine supplementation in peripheral arterial disease: no benefit and possible harm".

Teerlink T. Teerlink T. Circulation. 2008 Feb 12;117(6):e157; author reply e158. doi: 10.1161/CIRCULATIONAHA.107.729830. Circulation. 2008. PMID: 18268155 No abstract available.

2

ADMA metabolism and clearance.

Teerlink T. Teerlink T. Vasc Med. 2005 Jul;10 Suppl 1:S73-81. doi: 10.1191/1358863x05vm597oa. Vasc Med. 2005. PMID: 16444872 Review.

3

Cellular ADMA: regulation and action.

Teerlink T, Luo Z, Palm F, Wilcox CS. Teerlink T, et al. Pharmacol Res. 2009 Dec;60(6):448-60. doi: 10.1016/j.phrs.2009.08.002. Epub 2009 Aug 12. Pharmacol Res. 2009. PMID: 19682580 Free PMC article. Review.

4

The clinical significance of asymmetric dimethylarginine.

Siroen MP, Teerlink T, Nijveldt RJ, Prins HA, Richir MC, van Leeuwen PA. Siroen MP, et al. Among authors: teerlink t. Annu Rev Nutr. 2006;26:203-28. doi: 10.1146/annurev.nutr.26.061505.111320. Annu Rev Nutr. 2006. PMID: 16848705 Review.

5

Nitric oxide and kidney oxygenation.

Palm F, Teerlink T, Hansell P. Palm F, et al. Among authors: teerlink t. Curr Opin Nephrol Hypertens. 2009 Jan;18(1):68-73. doi: 10.1097/MNH.0b013e32831c4cdf. Curr Opin Nephrol Hypertens. 2009. PMID: 19077692 Review.

6

Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?

Schindhelm RK, van der Zwan LP, Teerlink T, Scheffer PG. Schindhelm RK, et al. Among authors: teerlink t. Clin Chem. 2009 Aug;55(8):1462-70. doi: 10.1373/clinchem.2009.126029. Epub 2009 Jun 25. Clin Chem. 2009. PMID: 19556446 Review.

7

HPLC analysis of ADMA and other methylated L-arginine analogs in biological fluids.

Teerlink T. Teerlink T. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 15;851(1-2):21-9. doi: 10.1016/j.jchromb.2006.07.024. Epub 2006 Aug 22. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 16931194 Review.

8

Elimination of asymmetric dimethylarginine by the kidney and the liver: a link to the development of multiple organ failure?

Nijveldt RJ, Siroen MP, Teerlink T, van Leeuwen PA. Nijveldt RJ, et al. Among authors: teerlink t. J Nutr. 2004 Oct;134(10 Suppl):2848S-2852S; discussion 2853S. doi: 10.1093/jn/134.10.2848S. J Nutr. 2004. PMID: 15465798 Free article. Review.

9

The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.

Richir MC, Bouwman RH, Teerlink T, Siroen MP, de Vries TP, van Leeuwen PA. Richir MC, et al. Among authors: teerlink t. JPEN J Parenter Enteral Nutr. 2008 Nov-Dec;32(6):613-21. doi: 10.1177/0148607108321702. JPEN J Parenter Enteral Nutr. 2008. PMID: 18974239 Review.

10

Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.

Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Schindhelm RK, et al. Among authors: teerlink t. Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):437-43. doi: 10.1002/dmrr.666. Diabetes Metab Res Rev. 2006. PMID: 16832839 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

128 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year